One Dimensional Continuum Falicov-Kimball Model in the Strongly Correlated Limit

In this paper we study the thermodynamics of the one dimensional continuum analogue of the Falicov-Kimball model in the strongly correlated limit using a method developed by Salsburg, Zwanzig and Kirkwood for the Takahashi gas. In the ground state it is found that the $f$ electrons form a cluster. The effect of including a Takahashi repulsion between $f$ particles is also studied where it is found that as the repulsion is increased the ground state $f$ electron configuration changes discontinuously from the clustered configuration to a homogeneous or equal spaced configuration analogous to the checkerboard configuration which arises in the lattice Falicov-Kimball model.Comment: 17 pages, Standard Latex File (UUencoded Postscript file of figures available upon request. To appear in physica A) MELB-MATHS-PP-1096783, email: [email protected]

Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout

ObjectiveThere is a lack of standardisation in the terminology used to describe gout. The aim of this project was to develop a consensus statement describing the recommended nomenclature for disease states of gout.MethodsA content analysis of gout-related articles from rheumatology and general internal medicine journals published over a 5-year period identified potential disease states and the labels commonly assigned to them. Based on these findings, experts in gout were invited to participate in a Delphi exercise and face-to-face consensus meeting to reach agreement on disease state labels and definitions.ResultsThe content analysis identified 13 unique disease states and a total of 63 unique labels. The Delphi exercise (n=76 respondents) and face-to-face meeting (n=35 attendees) established consensus agreement for eight disease state labels and definitions. The agreed labels were as follows: 'asymptomatic hyperuricaemia', 'asymptomatic monosodium urate crystal deposition', 'asymptomatic hyperuricaemia with monosodium urate crystal deposition', 'gout', 'tophaceous gout', 'erosive gout', 'first gout flare' and 'recurrent gout flares'. There was consensus agreement that the label 'gout' should be restricted to current or prior clinically evident disease caused by monosodium urate crystal deposition (gout flare, chronic gouty arthritis or subcutaneous tophus).ConclusionConsensus agreement has been established for the labels and definitions of eight gout disease states, including 'gout' itself. The Gout, Hyperuricaemia and Crystal-Associated Disease Network recommends the use of these labels when describing disease states of gout in research and clinical practice

Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout

OBJECTIVE: There is a lack of standardisation in the terminology used to describe gout. The aim of this project was to develop a consensus statement describing the recommended nomenclature for disease states of gout. METHODS: A content analysis of gout-related articles from rheumatology and general internal medicine journals published over a 5-year period identified potential disease states and the labels commonly assigned to them. Based on these findings, experts in gout were invited to participate in a Delphi exercise and face-to-face consensus meeting to reach agreement on disease state labels and definitions. RESULTS: The content analysis identified 13 unique disease states and a total of 63 unique labels. The Delphi exercise (n=76 respondents) and face-to-face meeting (n=35 attendees) established consensus agreement for eight disease state labels and definitions. The agreed labels were as follows: \u27asymptomatic hyperuricaemia\u27, \u27asymptomatic monosodium urate crystal deposition\u27, \u27asymptomatic hyperuricaemia with monosodium urate crystal deposition\u27, \u27gout\u27, \u27tophaceous gout\u27, \u27erosive gout\u27, \u27first gout flare\u27 and \u27recurrent gout flares\u27. There was consensus agreement that the label \u27gout\u27 should be restricted to current or prior clinically evident disease caused by monosodium urate crystal deposition (gout flare, chronic gouty arthritis or subcutaneous tophus). CONCLUSION: Consensus agreement has been established for the labels and definitions of eight gout disease states, including \u27gout\u27 itself. The Gout, Hyperuricaemia and Crystal-Associated Disease Network recommends the use of these labels when describing disease states of gout in research and clinical practice